Diagnosis and Management of Intraductal Papilloma

Diagnostic Approach

The American College of Radiology recommends mammography as the first-line imaging modality for evaluation of pathologic nipple discharge in patients ≥40 years 1
Ultrasonography is more sensitive than mammography and should be performed in all patients with pathologic nipple discharge, according to the American College of Radiology 1, 2
Ductography may demonstrate small lesions and localize the duct responsible for nipple discharge, but is technically challenging with 10-15% inadequate or incomplete results, as reported by the American College of Radiology 3

The American College of Radiology states that complete surgical excision is the standard management for intraductal papillomas diagnosed at biopsy, with a risk of malignancy upgrade of 3-14% 4, 5
Vacuum-assisted core needle biopsy can be both diagnostic and therapeutic, with cessation of nipple discharge in 90-97.2% of patients, but should not replace surgical duct excision due to high underestimation rate for high-risk lesions and DCIS, according to the American College of Radiology 4, 6
The American College of Radiology suggests that patients with non-bloody pathologic nipple discharge, benign CNB, or normal imaging may be considered for non-operative management if they don't have risk factors such as prior ipsilateral breast cancer, BRCA mutation, or atypia on CNB 4, 5

Bloody nipple discharge is a high-risk feature requiring surgical excision, as reported by the American College of Radiology and Praxis Medical Insights 6
Discordant imaging and pathology findings require surgical excision, according to the American College of Radiology and Praxis Medical Insights 4, 6
Male patients have a 57% risk of malignancy, and older age is associated with a 32% risk of malignancy in patients >60 years, as reported by Praxis Medical Insights 6

Intraductal papillomas carry a 3-14% risk of upgrade to malignancy, making tissue diagnosis essential before definitive surgical planning 7
Core needle biopsy is superior to FNA for distinguishing benign from malignant papillary lesions and provides adequate tissue for histologic characterization 7
The American College of Radiology recommends that when an intraductal lesion is identified on imaging, histologic diagnosis should be obtained through image-guided CNB 7

Vacuum-assisted CNB is particularly useful for complete sampling of small intraductal papillary lesions and may be both diagnostic and therapeutic, resulting in permanent cessation of nipple discharge in 90-97.2% of patients 7
A tissue marker should be placed at the end of biopsy to allow needle localization and excision if the biopsied lesion shows malignant or high-risk histology 7

The National Comprehensive Cancer Network guidelines recommend duct excision for patients with BI-RADS 1-3 or benign/indeterminate biopsy results, but this patient hasn't had tissue sampling yet 8
Obtaining CNB first allows for better surgical planning: if malignancy or high-risk lesion is found, the marker placed during biopsy guides more precise excision 7
If CNB shows atypia, DCIS, or invasive carcinoma, proceed to surgical excision with wire localization using the placed marker, followed by appropriate oncologic management 7, 8